IDERA PHARMACEUTICALS INC - COM NEW (IDRA)

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / COM NEW
Total 13F shares
41,185,293
Share change
-6,045,993
Total reported value
$81,541,129
Put/Call ratio
192%
Price per share
$1.98
Number of holders
78
Value change
-$15,468,511
Number of buys
35
Number of sells
33

Institutional Holders of IDERA PHARMACEUTICALS INC - COM NEW (IDRA) as of Q1 2016

As of 31 Mar 2016, IDERA PHARMACEUTICALS INC - COM NEW (IDRA) was held by 78 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 41,185,293 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, PUTNAM INVESTMENTS LLC, VANGUARD GROUP INC, JPMORGAN CHASE & CO, NATIXIS, Broadfin Capital, LLC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., FMR LLC, and Palo Alto Investors, LLC. This page lists 78 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.